These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28786254)

  • 21. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.
    Robson JC; Kiran A; Maskell J; Hutchings A; Arden N; Dasgupta B; Hamilton W; Emin A; Culliford D; Luqmani RA
    Ann Rheum Dis; 2015 Jan; 74(1):129-35. PubMed ID: 24095936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
    Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
    Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
    J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Gómez-Vaquero C; Marí-Alfonso B; Miranda-Filloy JA; Narvaez J; Ortego-Centeno N; Vicente EF; Blanco R; Amigo-Diaz E; Fernández-Gutiérrez B; Martin J; González-Gay MA
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S12-6. PubMed ID: 21269573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
    Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
    J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study.
    Robson JC; Kiran A; Maskell J; Hutchings A; Arden N; Dasgupta B; Hamilton W; Emin A; Culliford D; Luqmani R
    J Rheumatol; 2016 Jun; 43(6):1085-92. PubMed ID: 27084910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
    Uddhammar A; Eriksson AL; Nyström L; Stenling R; Rantapää-Dahlqvist S
    J Rheumatol; 2002 Apr; 29(4):737-42. PubMed ID: 11950015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
    Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
    Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of infections in patients with giant cell arteritis: a cohort study.
    Durand M; Thomas SL
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):581-8. PubMed ID: 22184094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Giant cell arteritis and cardiovascular disease in older adults.
    Ray JG; Mamdani MM; Geerts WH
    Heart; 2005 Mar; 91(3):324-8. PubMed ID: 15710711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort.
    Singh AG; Kermani TA; Crowson CS; Weyand CM; Matteson EL; Warrington KJ
    J Rheumatol; 2015 Feb; 42(2):309-15. PubMed ID: 25512481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events.
    Lozano E; Segarra M; Corbera-Bellalta M; García-Martínez A; Espígol-Frigolé G; Plà-Campo A; Hernández-Rodríguez J; Cid MC
    Ann Rheum Dis; 2010 Feb; 69(2):434-42. PubMed ID: 19289383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.
    Baldini M; Maugeri N; Ramirez GA; Giacomassi C; Castiglioni A; Prieto-González S; Corbera-Bellalta M; Di Comite G; Papa I; Dell'antonio G; Ammirati E; Cuccovillo I; Vecchio V; Mantovani A; Rovere-Querini P; Sabbadini MG; Cid MC; Manfredi AA
    Arthritis Rheum; 2012 Mar; 64(3):854-65. PubMed ID: 21989653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular diseases and their associations with lipid parameters and endothelial dysfunction in giant cell arteritis.
    Jud P; Hafner F; Meinitzer A; Brodmann M; Dejaco C; Silbernagel G
    RMD Open; 2023 Sep; 9(3):. PubMed ID: 37657846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for cranial ischemic complications in giant cell arteritis.
    Nesher G; Berkun Y; Mates M; Baras M; Nesher R; Rubinow A; Sonnenblick M
    Medicine (Baltimore); 2004 Mar; 83(2):114-122. PubMed ID: 15028965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
    Li L; Neogi T; Jick S
    Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.
    Chen JJ; Leavitt JA; Fang C; Crowson CS; Matteson EL; Warrington KJ
    Ophthalmology; 2016 Sep; 123(9):1999-2003. PubMed ID: 27297405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.